Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia
- 7 August 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (32), 12988-12993
- https://doi.org/10.1073/pnas.0704754104
Abstract
Intimal hyperplasia (IH) and restenosis limit the long-term utility of bypass surgery and angioplasty due to pathological proliferation and migration of vascular smooth muscle cells (VSMCs) into the intima of treated vessels. Consequently, much attention has been focused on developing inhibitory agents that reduce this pathogenic process. The E2F transcription factors are key cell cycle regulators that play important roles in modulating cell proliferation and cell fate. Nonselective E2F inhibitors have thus been extensively evaluated for this purpose. Surprisingly, these E2F inhibitors have failed to reduce IH. These findings prompted us to evaluate the roles of different E2Fs during IH to determine how selective targeting of E2F isoforms impacts VSMC proliferation. Importantly, we show that E2F3 promotes proliferation of VSMCs leading to increased IH, whereas E2F4 inhibits this pathological response. Furthermore, we use RNA probes to show that selective inhibition of E2F3, not global inhibition of E2F activity, significantly reduces VSMC proliferation and limits IH in murine bypass grafts.This publication has 47 references indexed in Scilit:
- The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: Study rationale, design, and baseline patient characteristicsAmerican Heart Journal, 2005
- Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgeryDiabetes, Obesity and Metabolism, 2005
- New targets for PPARγ in the vessel wall: implications for restenosisInternational Journal of Obesity, 2005
- Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.Vascular and Endovascular Surgery, 2005
- Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Expression of Cell Cycle Regulators During Smooth Muscle Cell Proliferation After Balloon Catheter Injury of Rat ArteryJournal of Korean Medical Science, 2004
- Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft modelJournal of Vascular Surgery, 2002
- Regulation of Vascular Smooth Muscle Growth by α1-Adrenoreceptor Subtypes in Vitro and in SituOnline Journal of Public Health Informatics, 1995
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990